Changes of dopamine transporter function in striatum during acute morphine addiction and its abstinence in rhesus monkey

Chinese Medical Journal

Volumn 119, Issue 21, 2006, Pages 1802-1807

  Xiao, Zhuang Wei ^a   Cao, Chu Yu ^a   Wang, Zhao Xin ^a,b   Li, Jun Xiong ^a   Liao, Hai Yong ^a   Zhang, Xue Xin ^a,c  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dopamine transporter; Morphine; Striatum

Indexed keywords

DOPAMINE TRANSPORTER; MORPHINE; PERTECHNETIC ACID TC 99M; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCULATION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; DRUG WITHDRAWAL; FEMALE; MALE; MORPHINE ADDICTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHESUS MONKEY; SIGNAL DETECTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION;

EID: 33751072629     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200611010-00007     Document Type: Article

References (22)

1. Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov 2002; 1: 710-726.
2. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 2004; 12: 305-320.
3. Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M, et al. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry 1998; 155: 832-834.
4. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158: 377-382.
5. Laine TP, Ahonen A, Tomiainen P, Heikkila J, Pyhtinen J, Rasanen P, et al. Dopamine transporters increase in human brain after alcohol withdrawal. Mol Psychiatry 1999; 4: 189-191, 104-105.
6. Kuikka JT, Akerman K, Bergstrom KA, Karhu J, Hiltunen J, Haukka J, et al. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl) nortropane for dopamine transporter imaging in the living human brain. Eur J Nucl Med 1995; 22: 682-686.
7. Liu XD, Lin XT. Age and sex can affect the DAT Level. Chin J Nucl Med (Chin) 2000; 36: 263-265.
8. O'Doherty JP. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr Opin Neurobiol 2004; 14: 769-776.
9. van der Stelt M, Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 2003; 480: 133-150.
10. 99mTc-TRODAT-1 SPECT study. J Affect Disord 2005; 89: 115-123.
11. 99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 1997; 24: 372-380.
12. Zheng JW, Xu GZ, Shi J, Jia SW. Brain functional imaging studies in drug abusers. J Peking Univ (Health Sci) (Chin) 2002; 34: 530-535.
13. Zhang XD, Guo XH, Guo L, Zhang ZM, Zhang ZX, Zheng CL, et al. Establishment of animal model of heroin-dependent macaca mulatta. Chin J Mod Appl Pharm (Chin) 1999; 16: 14-16.
14. Gudehithlu KP, Bhargava HN. Modification of the characteristics of dopamine transporter in brain regions and spinal cord of morphine tolerant and abstinent rats. Neuropharmacology 1996; 35: 169-174.
15. Hashimoto K, Tsukada H, Nishiyama S, Fukumoto D, Kakiuchi T, Shimizu E, et al. Effects of N-acetyl-L-cysteine on the reduction of brain dopamine transporters in monkey treated with methamphetamine. Ann N Y Acad Sci 2004; 1025: 231-235.
16. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR. Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 1997; 282: 834-838.
17. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606-612.
18. Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992; 12: 483-488.
19. Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J Pharmacol Exp Ther 2001; 298: 129-140.
20. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997; 388: 586-589.
21. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 1998; 95: 4029-4034.
22. Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, et al. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 1999; 2: 649-655.